Clinical response to immune checkpoint inhibitors in immunocompromised patient with metastatic non-melanoma skin cancer
Saved in:
| Main Authors: | P. Díaz Morales, P. Naranjo Álamo, E.N. Castro González, I. Castaño González |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824002106 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors
by: Marco Meazza Prina, et al.
Published: (2024-12-01) -
Efficacy of immune checkpoint inhibitors for in-transit melanoma
by: Victoria Atkinson, et al.
Published: (2020-05-01) -
Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory study
by: Yujie Zhao, et al.
Published: (2025-03-01) -
Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanoma
by: Grant A McArthur, et al.
Published: (2025-05-01) -
Immune Checkpoint Inhibitors in Melanoma Treatment: Advances and Obstacles
by: A. V. Sultanbaev
Published: (2025-04-01)